US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Antisense & RNAi Technology Market Research Reports & Industry Analysis

Find comprehensive market research and company reports on the AntiSense & RNAi Technology Industry. More specifically, find reports on the Cancer Therapies, Bioinformatics and Bioprocessing markets. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
RSS Feeds

Antisense & RNAi Technology Industry Research & Market Reports

< prev 1    3  
Genome Editing Global Market - Forecast to 2022
9/21/2016 | published by: IQ4I Research and Consultancy
... a continuous evolution of gene modification technique starting from restriction endonucleases, transgenic breeding, RNAi technologies to the current engineered endonucleases. Over the last several decades, technologies for identification, isolation, sequencing, replication and integration of desired ...  |  read more...
USD 4,950
RNA (miRNA, RNAi & siRNA) Therapies in Cancer: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... empower biotech/pharma professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early ...  |  read more...
USD 14,250
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... treatment of more than 41 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 90 drug targets that are included in this drug-pathway analyzing tool. ...  |  read more...
USD 2,250
30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... or protein-based therapies. There are today 103 companies plus partners developing 131 RNA (miRNA, RNAi & siRNA) drugs in 198 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number ...  |  read more...
USD 4,485
MicroRNA Tools and Services Market
5/3/2016 | published by: Kalorama Information
... to clinical applications. The report includes the following market information: Estimated Market Breakdown by Tools and Services, 2015 Estimated Market Breakdown by Geographic Region, 2015 (North America, Europe, ROW) Global Revenues and Forecast for the ...  |  read more...
USD 4,200
Global RNAi for Therapeutic Consumption Market 2016 Industry Trend and Forecast 2021
6/1/2016 | published by: QYResearch Group
... overview of the RNAi for Therapeutic industry including definitions, classifications, applications and industry chain structure. Development policies and plans are discussed as well as manufacturing processes are also analyzed. The report then analyzes the global ...  |  read more...
USD 4,000
RNAi Technology - Market size, segmentation, market share and competitive landscape (2016-2021)
6/1/2016 | published by: Mordor Intelligence LLP
... with a CAGR of 20.19%. RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments of the nucleic acid. The major drivers ...  |  read more...
USD 500
Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020
11/24/2015 | published by: MarketsandMarkets
... synthesis market is poised to reach USD 1,918.6 million by 2020 from USD 1,078.1 million in 2015, growing at a CAGR of 10.1% from 2015 to 2020. This market is categorized on the basis of ...  |  read more...
USD 5,650
Global CRISPR Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021
1/6/2016 | published by: Occams Business Research & Consultancy
... is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the ...  |  read more...
USD 4,000
Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights, 2016
2/1/2016 | published by: DelveInsight
... protein have been identified by therapeutics based on RNA interference (RNAi). RNA interference (RNAi), a process in recovery Phase, is still keeping the expectations of the many mid Pharma companies at a higher end with ...  |  read more...
USD 2,250
RNAi Therapeutics Market, 2015 - 2030
12/1/2015 | published by: Roots Analysis
... involving short strands of nucleic acids. It is a regulatory process that cells utilise to silence and/or inhibit gene expression through the destruction of specific mRNA molecules. One of the major advantages of RNAi is ...  |  read more...
USD 2,199
RNAi Technologies and Global Markets
1/1/2016 | published by: BCC Research
... 8.4%. This report provides: An overview of the global market for RNAi technologies which are used in the areas of drug delivery, therapeutics, and diagnostics Analyses of global market trends, with data from 2014, estimates ...  |  read more...
USD 6,650
Antisense Therapeutics Limited - Product Pipeline Review - 2015
11/18/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Antisense Therapeutics Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Conference Documentation: RNA Therapeutics
2/16/2016 | published by: SMI Publishing, Ltd
... in oncology, cardiovascular injury, and ophthalmology, and open the floor for discussion to review existing and emerging concepts in delivery systems, oligonucleotides, aptamer-conjugates as well as messenger RNA therapeutics. The biggest challenge in enabling RNAi ...  |  read more...
USD 789
Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019
5/7/2015 | published by: MarketsandMarkets
... 2019 In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant ...  |  read more...
USD 5,650
RNAi for Therapeutic Applications: Technology and Market Forecast 2015-2025
6/24/2015 | published by: Visiongain
... you potential revenues to 2025, assessing data, trends, opportunities and prospects there. Our 180-page report provides 95 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our ...  |  read more...
USD 2,519
PharmaSphere: Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis
9/1/2015 | published by: GlobalData
... therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends, GlobalData provides an in-depth analysis of the current and future growth drivers of the RNAi therapy market. The report discusses the key ...  |  read more...
USD 2,995
Global Antisense and RNAi Therapeutics Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... is a RNA-based gene silencing process in which RNA molecules inhibit gene expression by destructing definite mRNA molecules. Antisense technology involves the synthesis of a strand of nucleic acid that would bind to an mRNA ...  |  read more...
USD 2,500
Global miRNA Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional ...  |  read more...
USD 2,500
Conference Documentation: RNA Therapeutics
2/16/2015 | published by: SMI Publishing, Ltd
... cancer, genetic disorders, cardiovascular disease and autoimmune disorders. Recent advances in small interfering RNA delivery and target selection provide unprecedented opportunities for clinical translation and positioning in the market place. This conference offers the opportunity ...  |  read more...
USD 788.78
2015 Analysis of Emerging Nucleic Acid Testing Assays, and Strategic Profiles of Leading Suppliers
1/23/2015 | published by:
... as well as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, ...  |  read more...
USD 3,500
2015 Analysis of Nucleic Acid Testing Instrumentation, and Strategic Profiles of Leading Suppliers
1/23/2015 | published by:
... facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews ...  |  read more...
USD 3,500
The U.S. Market and Developments Associated with Psoriasis
7/1/2001 | published by: Kalorama Information
... the potential for actual curative therapy. This dedicated report from Kalorama Information examines the current and future market for therapeutic agents, including " Natural" approaches in the treatment of psoriasis. Product areas include: Current Products/methods ...  |  read more...
USD 1,496
< prev 1    3